GlassScriptPhysician profile
Simon M Adanin
NPI 1922241124
$3,850.55
in general payments reported to CMS, 2019-2025
23 companies · $88.77 in 2025
The $88.77 reported for 2025 was more than what a typical Anesthesiology provider received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $464 · 2020: $303 · 2021: $1,622 · 2022: $954 · 2023: $181 · 2024: $238 · 2025: $88.77.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $508.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $507.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spinal Simplicity, LLC | $1,050.33 | 2021-2022 | |
| Verathon INC. | $595.00 | 2021 | |
| Abbott Laboratories | $496.65 | 2019-2023 | Proclaim |
| Medtronic USA, INC. | $260.50 | 2019-2020 | |
| Boston Scientific Corporation | $215.75 | 2019-2022 | |
| Foundation Fusion Solutions, LLC | $180.23 | 2021-2023 | |
| Pacira Pharmaceuticals Incorporated | $164.46 | 2022-2025 | Exparel |
| Becton, Dickinson and Company | $154.41 | 2024-2025 | Hemosphere |
| Medtronic, INC. | $116.14 | 2021-2023 | Kyphon Express II Kyphopak Tray |
| Stryker Corporation | $102.63 | 2020-2021 | |
| Vertiflex, INC. | $78.08 | 2019 | |
| Nevro Corp. | $74.66 | 2019-2020 | |
| Si-Bone, INC. | $66.36 | 2021-2022 | |
| Saluda Medical Americas, INC. | $52.27 | 2022 | |
| Stimwave Technologies Incorporated | $48.65 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $38.93 | 2023 | Hemosphere |
| Painteq LLC | $29.23 | 2021-2022 | |
| Vertos Medical, INC. | $25.00 | 2022 | |
| Relievant Medsystems, INC. | $22.22 | 2023 | Intracept |
| Takeda Pharmaceuticals U.S.A., INC. | $21.69 | 2024 | Entyvio |
| Ironwood Pharmaceuticals, INC | $21.33 | 2023 | Linzess |
| Stratus Medical, LLC | $18.17 | 2023 | Nimbus |
| Merck Sharp & Dohme LLC | $17.86 | 2023 | Bridion |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Simon Adanin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.